# A Study of Intravenous Perampanel in Japanese Participants With Epilepsy

> **NCT03754582** · PHASE2 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 21 (actual)

## Conditions studied

- Epilepsy
- Seizures

## Interventions

- **DRUG:** Perampanel
- **DRUG:** Perampanel

## Key facts

- **NCT ID:** NCT03754582
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-27
- **Primary completion:** 2019-12-10
- **Final completion:** 2019-12-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03754582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03754582, "A Study of Intravenous Perampanel in Japanese Participants With Epilepsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03754582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*